Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

Xinxin Peng(Shanxi Medical University), Michael S. Noble(Broad Institute), Jiashan Zhang, Zhongming Zhao(Vanderbilt University), Zhongqi Ge(The University of Texas MD Anderson Cancer Center), Kıvanç Birsoy(Rockefeller University), Juok Cho(Wellcome Sanger Institute), Ina Felau(National Cancer Institute), Timothy Defreitas, Feixiong Cheng(Cleveland Clinic Lerner College of Medicine), Heidi J. Sofia, Farshad Farshidfar(Institute for Stem Cell Biology and Regenerative Medicine), Rashi Naresh, John N. Weinstein(The University of Texas MD Anderson Cancer Center), Roy Tarnuzzer(University of Central Florida), Di Du(The University of Texas MD Anderson Cancer Center), Melpomeni Kasapi, John A. Demchok(National Cancer Institute), Carolyn M. Hutter(National Human Genome Research Institute), Sudha Chudamani, Martin L. Ferguson(National Cancer Institute), Scott Frazer, Rory Johnson(University College Dublin), Xu Xiaoyan(China Medical University), Philip L. Lorenzi(City Of Hope National Medical Center), Kamalika Mojumdar(The University of Texas MD Anderson Cancer Center), Laxmi Lolla(Windber Research Institute), David I. Heiman(Broad Institute), Nils Gehlenborg(Harvard University), Lingxiang Liu(Jiangsu Province Hospital), Michael S. Lawrence(Broad Institute), Todd Pihl, George Thomas(Oregon Health & Science University), Calena R. Marchand(University of Waterloo), Jia Liu(Nanjing Tech University), Liming Yang(Nanjing Forestry University), Yumeng Wang(Heidelberg University), Qiang Sun(Xi'an University of Science and Technology), Lin Tan(The University of Texas MD Anderson Cancer Center), Zhongyuan Chen(The University of Texas MD Anderson Cancer Center), Ye Wu(Capital Medical University), Yunhu Wan, Huiwen Zhang(The University of Texas Health Science Center at Houston), Gad Getz(Broad Institute), Pei Lin, Jean C. Zenklusen(National Cancer Institute)
Cell Reports
April 1, 2018
Cited by 396


Related Papers